Your browser doesn't support javascript.
loading
A novel flavonoid, 6-C-beta-d-glucopyranosyl-(2S,3S)-(+)-3',4',5,7-tetrahydroxyflavanone, isolated from Ulmus wallichiana Planchon mitigates ovariectomy-induced osteoporosis in rats.
Sharan, Kunal; Swarnkar, Gaurav; Siddiqui, Jawed A; Kumar, Avinash; Rawat, Preeti; Kumar, Manmeet; Nagar, Geet K; Manickavasagam, Lakshmi; Singh, Sheelendra P; Mishra, Geetanjali; Jain, Girish K; Maurya, Rakesh; Chattopadhyay, Naibedya.
Affiliation
  • Sharan K; Division of Endocrinology, Central Drug Research Institute (Council of Scientific and Industrial Research), Chattar Manzil, Lucknow, India.
Menopause ; 17(3): 577-86, 2010.
Article in En | MEDLINE | ID: mdl-20393370
OBJECTIVE: The aim of this study was to determine the skeletal effect of 6-C-beta-d-glucopyranosyl-(2S,3S)-(+)-3',4',5,7-tetrahydroxyflavanone (GTDF)/Ulmoside A, a new compound isolated from the extract of Ulmus wallichiana in a rat model of postmenopausal bone loss. METHODS: GTDF (1.0 and 5.0 mg kg d) was given orally to ovariectomized (OVx) rats (180-200 g) for 12 weeks. Sham operated + vehicle, ovariectomy + 17beta-estradiol (2.5 microg kg d), and ovariectomy + vehicle groups served as various controls. Bone mineral density (BMD), trabecular microarchitecture, bone biomechanical strength, levels of bone turnover/resorption markers, uterotropic effect, and plasma pharmacokinetics were studied. One-way analysis of variance was used to test significance of effects. RESULTS: OVx rats treated with both doses of GTDF exhibited significantly higher BMD in the trabecular (distal femur, proximal tibia, and vertebrae) and cortical (femur shaft) regions compared with the ovariectomy + vehicle group. Micro-CT demonstrated that OVx rats treated with 5.0 mg kg day of GTDF had better bone microarchitectural parameters compared with the ovariectomy + vehicle group. Serum osteocalcin and urinary C-terminal teleopeptide of Type I collagen levels in OVx rats treated with GTDF (at both doses) were significantly lower than those in the ovariectomy + vehicle group. At neither of the two doses did GTDF exhibit uterine estrogenicity. A pharmacokinetic study revealed that GTDF achieved maximum plasma concentration (40.67 ng mL) at approximately 1 hour, indicating its slow absorption. Its absolute bioavailability was found to be 1.04% with a plasma elimination half-life of approximately 5 hours. CONCLUSIONS: GTDF, a novel compound isolated from U wallichiana extract, improves bone biomechanical quality through positive modifications of BMD and trabecular microarchitecture without a hyperplastic effect on the uterus.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Osteoporosis / Flavonoids / Bone Density / Ulmus / Glycosides Language: En Journal: Menopause Year: 2010 Type: Article Affiliation country: India

Full text: 1 Database: MEDLINE Main subject: Osteoporosis / Flavonoids / Bone Density / Ulmus / Glycosides Language: En Journal: Menopause Year: 2010 Type: Article Affiliation country: India